Clinical White Papers and Case Studies

  1. Why RWD Strategy Can't Wait With Price, Value And Evidence Pressures Everywhere 4/27/2026

    Overcome pricing pressures and reimbursement delays by integrating real-world evidence early in development to align clinical outcomes with payer demands and accelerate patient access.

  2. Why Life Science Organizations Need A Chief Patient Officer Function 4/27/2026

    Bridging the gap between innovation and impact, this exploration of the Chief Patient Officer role offers a strategic framework to integrate patient insights and de-risk the product lifecycle.

  3. Access And Retention In Metastatic Colorectal Cancer Trials 4/21/2026

    Making it easier for participants in metastatic colorectal cancer trials to reach specialized sites and stay on schedule with managed travel, lodging, and reimbursements

  4. Participant Support In Oncology Trials With Cachexia-Related Burden 4/21/2026

    Coordinated travel, reimbursements, and visit logistics for oncology participants experiencing fatigue, weight loss, and reduced mobility, helping reduce dropouts and keep people engaged.

  5. Scaling Global Vaccine Mega-Trials For A Top Five Pharma 4/16/2026

    See how high-volume enrollment, dynamic safety data capture, and rapid iteration can support global studies operating under intense timelines and scale.

  6. The Next Era Of eCOA Is AI 4/15/2026

    Discover how AI is moving beyond the hype to streamline clinical study builds. Explore practical ways to automate protocol digitization and UAT scripts while preparing for future patient tools.

  7. Trial Rescue And Reconnaissance 4/15/2026

    Explore a strategic partnership that resulted in a rescue plan for a Phase III oncology trial that was facing high site decline rates.

  8. Pharma R&D Annual Review Supplement: New Active Substances 4/15/2026

    Last year was by some distance the best year ever in terms of new active substances. Explore the 105 new debuts that easily outstrips that of the previous record holder, 2021’s, 97.

  9. Futureproofing Post-Approval Compliance 4/15/2026

    In the post-approval stage, a synergistic operating model brings PV and regulatory functions under one umbrella: a single governance structure with shared decision cycles, templates, and evidence.

  10. GA Screening: Early Detection For Future Trial Recruitment 4/9/2026

    Community-based screenings identify undiagnosed eye disease at high rates, creating a scalable, high-trust pathway for early intervention and improved clinical research recruitment.